Get started
Author

Yu‐Hung Wang

Observed names: Wang, Yu-Hung, Y. Wang, Y.-H. Wang, Y.‐H. Wang, Yu-Hung Wang, YuHung Wang
Observed institutions: National Taiwan University, University of Manchester, Yale University, Far Eastern Memorial Hospital, Cancer Research UK Manchester Institute, National Taiwan University Hospital, The Christie NHS Foundation Trust
ORCID: 0000-0003-4483-5627
Observed ORCID: 0000-0003-4483-5627
OpenAlex ID: A5000152081
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
2020 · Yu-Hung Wang, Chien-Chin Lin, et al. · Annals of Hematology · 47
PDF
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
2021 · Yu-Hung Wang, Hsin-An Hou, et al. · Blood Advances · 34
PDF
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
2024 · Maria Julia Montoro, Laura Palomo, et al. · Blood · 31
A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients
2020 · Yu-Hung Wang, Chien-Chin Lin, et al. · Blood Advances · 22
PDF
Hepatitis B reactivation during treatment of tyrosine kinase inhibitors—Experience in 142 adult patients with chronic myeloid leukemia
2019 · Yu-Hung Wang, Ja-Der Liang, et al. · Leukemia Research · 22
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
2020 · Yu-Hung Wang, Chien-Chin Lin, et al. · Blood Cancer Journal · 16
PDF
High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
2023 · Yu-Hung Wang, Chien-Chin Lin, et al. · Blood Advances · 14
PDF
Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization
2025 · Hasse M. Addinsell, Rachel Cant, et al. · Leukemia · 11
PDF
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
2024 · Chi-Yuan Yao, Chien-Chin Lin, et al. · Blood Advances · 9
PDF
The expression levels of long non‐coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes
2020 · Sheng‐Yu Hung, Chien‐Chin Lin, et al. · British Journal of Haematology · 9
PDF
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology
2024 · Matteo G Della Porta, Jan Philipp Bewersdorf, et al. · Histopathology · 8
Heterogeneity in outcomes of TP53 ‐mutated myeloproliferative neoplasms based on disease phenotype and mutational status
2025 · Talha Badar, James M. Foran, et al. · British Journal of Haematology · 7
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
2024 · Adrian Mosquera Orgueira, Manuel Mateo Perez Encinas, et al. · British Journal of Haematology · 7
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome
2021 · Yu‐Hung Wang, Chien‐Chin Lin, et al. · British Journal of Haematology · 7
PDF
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
2026 · Luca Lanino, Anthony M. Hunter, et al. · Journal of Clinical Oncology · 5
The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression
2022 · Chi-Yuan Yao, Chien-Chin Lin, et al. · Journal of the Formosan Medical Association · 5
PDF
Stem cell transplant for mantle cell lymphoma in Taiwan
2022 · Yu-Hung Wang, Ching-Yun Hsieh, et al. · Scientific Reports · 5
PDF
Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
2021 · Yu‐Hung Wang, Feng‐Ming Tien, et al. · Cancer Reports · 5
PDF
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study
2024 · Yu-Hung Wang, Chao-Hung Wei, et al. · Leukemia · 4
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
2024 · Yu-Hung Wang, Chien-Chin Lin, et al. · Blood Cancer Journal · 4
PDF
Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
2022 · Yu‐Hung Wang, Chi‐Yuan Yao, et al. · eJHaem · 4
PDF
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
2020 · Yu-Hung Wang, Shan-Chi Yu, et al. · International Journal of Hematology · 4
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)
2024 · Luca Lanino, Anthony M. Hunter, et al. · Blood · 3
PDF
IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo
2024 · Chien‐Chin Lin, Chi‐Yuan Yao, et al. · eJHaem · 3
PDF
Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients
2024 · Yu-Hung Wang, Adrián Mosquera Orgueira, et al. · Scientific Reports · 3
Works count: 86
Citation count: 321
H-index: 9
I10-index: 8
Year
Topic
Type